Knowledge (XXG)

talk:WikiProject Pharmacology/Categorization - Knowledge (XXG)

Source 📝

99: 81: 50: 1015:, I think you have been doing a great job, particularly with the conversion table. However, I feel that the proposed dermatologic categorization is becoming too complicated. What would you think about simply having only the first level ATC derm cats, and just categorize everything at that level without further subdivision? --- 579:, using ATC code S as an example of how it will start to look when expanded. I tried to style the table more with some borders around each group (like a fine border encompassing all the code S rows) but couldn't figure out how to do it. Any additional improvements you can make to the table would be greatly appreciated. --- 685:
Ok, I added in some of the derm categories just to better develop the rough draft, not to suggest the categories I have used are going to stay that way. In fact, please consolidate where desired. Perhaps some of you other editors can help me design the derm scheme? Also, perhaps we should somehow
194:
What about arranging the categorisation scheme like the ATC tree? Since some of the categories will have more than one parent, we can't avoid some categories appearing in the scheme several times (at least I can't think of a way) – and this would give us an "ATC code to category conversion table" and
167:
Now that we have consensus that consolidating ATC categories when possible is the way to go, I think it would be helpful to have an "ATC code to category conversion table," so editors can easily look up where a drug should be placed. With that being said, how should the table be structured? Perhaps
535:
I think the tree gives us a nice view of how the structure looks/is developing, while the table gives us an easy reference to see where categories have been consolidated. With that being said, I like the additional cross reference column you created. Are there any other columns you think we should
1199:(Antibiotics and chemotherapeutics for dermatologic use). This one will get rather large, and overlap heavily with other ATC groups (J Antiinfectives, G01 Gynaecological antiinfectives, S01 Ophthalmologicals). Maybe breaking it down to third or fourth level would make matters simpler in this case. 783:
I think since this is simply a conversion table we shouldn't get to fancy merging cells, but, when needed, simply list the same category twice. So for D01B and D01BA, I would prefer to simply list the "Systemic antifungals" category twice. How do you feel about
888:. As always, feel free to change anything you don't like. I also merged table rows again since the formatting (italics/other ATC codes) gets a bit confusing otherwise in my opinion. Please tell me if you find a better solution (or just change it). Thanks -- 554:
I can't think of any other important columns. Other links (like to the corresponding articles) can be included in the category headers, otherwise the table might get a bit bloated. What do you mean with your last question? Where could other levels link to?
290:
Thanks for your comment. I would tend to favor having both the category tree view and a conversion table as I think combining them might make organization a big more cumbersome. So, for your example, I would display the information as follows:
809:
For ATC codes with terms like "other" or "various," like "D04AX Other antipruritics," should we just categorize those drugs in the category that is found immediately above? So for the drugs under D04AX, we would put them in the category for
742:
I have marked ATC codes with no corresponding categories with a "—" (e.g. empty ATC groups or groups with only combination products which don't need their own WP articles). Probably needs an explaining sentence at the top; but how does that
1094:
Could you wait with D03, D07 and the antihistamines (or just have a look at the issues I posted above)? The internet access here is way to slow for some useful recherche and/or discussion. I'll be properly back in two weeks' time. Thanks
746:
I'd propose only going down to level 3 in the following groups: D02, D03, D05, D09; otherwise the categories will get very small. This isn't saying I want all the other ATC codes split down to level 4; I'm not sure about
1069: 605:, but that looks disastrous. I think we are fine with the different background colours; but I have added an additional caption line above each section... the table will get rather long. Please revert if you disagree. -- 661:
At the moment, they look a bit erratic, but we'll be fine if we put them on separate pages (or on one page with section headers in between – perhaps we should wait and see how long they really get before splitting).
818: 153: 631:
I separated all the first level codes into their own tables; how does that look? Perhaps we should move these ATC to category conversion tables to their own page since they're going to get long? ---
885: 777: 576: 176: 1151: 963: 491: 441: 357: 372: 310: 207: 195:
a categorisation scheme in one go. To avoid (or reduce) confusion because of the categories appearing several times, we could add cross references. Something like this:
733:
I did a bit of expanding to the ATC code D table. As your additions, mine are open to change – please rename categories, undo changes or whatever you think appropriate.
1166:
glucocorticoids, not preparations, and 2. we would avoid double categorisation of oral and topical GCs; many of these substances can be used both ways anyway.
1241: 1236: 1246: 1030:
That was my original intention (some months ago) until someone pointed out that some of the lower levels correspond to pharmacological categories (e. g.
821:, 4.), and Physchim62 did likewise somewhere below. I don't think anyone objected, so I'd do the same for lower levels. Unless there is a better idea? -- 115: 17: 739:
Where there is only one subgroup of a group (e.g. D01BA), we need only one category. Is my layout (one category reference spanning two rows) fine?
444:. Of course, we can add additional stylization to the tree or table to make things even easier to read/better organized. What do you think? --- 1189: 1043: 304: 198: 106: 86: 929: 846:
What about simply omitting the level 4 categories in the table (and mentioning the fact on top of the page)? Would that be confusing? --
1174: 701:
It would be good to distinguish the "bottom level" categories form those that should only contain subcategories. For example, D -: -->
949: 396: 322: 230: 1184:
down to fourth level because antihistamines (D04AA) and local anaesthetics (D04AB) are in some other branches of ATC as well,
987: 61: 983: 420: 332: 245: 481:" (linking to the relevant section; but this could cause maintenance problems in case the name of the ATC section changes). 1039: 902:
The category names I added to section D are tentative. Please comment or just change them if you have any better ideas.
1213: 1118: 1104: 1081: 1059: 1024: 1007: 897: 874: 855: 830: 800: 764: 726: 712: 695: 671: 640: 614: 588: 564: 545: 529: 453: 284: 188: 462:
I am not sure whether there are advantages of having the scheme twice in different layouts, but I have no objections.
839:
I am fine simply categorizing D02, D03, D05, D09 only to level three, but how should we denote that on the table?
575:
After thinking about it, I believe leaving ATC codes like "S01ED" unlinked is fine. Also, I have put together a
1031: 945: 408: 327: 239: 1147: 967: 67: 602: 1047: 925: 1035: 507: 432: 384: 337: 315: 251: 216: 473:
ED" (linking to the ATC code page) or simply "S01ED" (no link, since there is already one from the row "
114:
on Knowledge (XXG). If you would like to participate, please visit the project page, where you can join
27: 1209: 1100: 1055: 1003: 893: 851: 826: 796: 760: 722: 708: 667: 610: 560: 525: 280: 956:
antagonists but inverse agonists. Perhaps the existing category (and the article) should be renamed.
177:
Knowledge (XXG):WikiProject_Pharmacology/Categorization/Scheme#ATC_code_to_category_conversion_table
601:
As far as I know, HTML supports only borders around a whole table or around a single cell. I tried
1155: 1114: 1077: 1020: 870: 691: 636: 584: 541: 449: 184: 819:
Knowledge (XXG) talk:WikiProject Pharmacology/Categorization/Archive 1#ATC based categories
1205: 1096: 1051: 1012: 999: 889: 847: 822: 792: 756: 718: 704: 663: 606: 556: 521: 276: 536:
add? Also, with regard to links, should we just have links to the first level codes? ---
1159: 466: 427: 1230: 415: 1046:
plus its subcategories would be useful; however most of the lower level categories (
686:
indent the third and fourth level category rows somehow, to improve readability? ---
98: 80: 1196: 1181: 1170: 1143: 991: 979: 973: 959: 941: 909: 512: 478: 474: 470: 403: 379: 256: 235: 212: 111: 1110: 1073: 1016: 982:: Should the subcategory D10A be broken down to 4th level? Do we even need D10A 866: 687: 632: 580: 537: 445: 180: 703:
Azoles is of the first kind. What about printing the first kind in boldface? --
391: 367: 226: 203: 169: 921:
for treatment of wounds and ulcers? (to concur with the other category names)
1070:
Knowledge (XXG):WikiProject Medicine/Dermatology task force/Categorization
998:
As always, feel free to change anything you think appropriate. Thanks --
933: 275:
And I apologise to kilbad for not using ATC code D as an example ;-) --
484:
It would be nice to include the cross refs. What do you think of this:
175:
Regardless, I have created a section for the table to be placed in at
1068:
Ok, I have inserted the level one ATC derm cats into the scheme at
1072:. If those look ok to you, I may start categorizing articles? --- 750:
Indenting categories is a good idea, but I can't work that out.
1042:). I think these cross-refs between the ATC category tree and 886:
Knowledge (XXG):WikiProject Pharmacology/Categorization/Tables
884:
I did a bit of formatting and put some explanations on top of
778:
Knowledge (XXG):WikiProject_Pharmacology/Categorization/Tables
147: 43: 702:
Dermatologic drugs is of the second kind, while D01AC -: -->
1050:
etc.) could indeed be left out as far as I am concerned. --
35: 163:
Creation of an "ATC code to category conversion table"
1152:
Category:Dermatologic preparations of corticosteroids
964:
Category:Dermatologic preparations of corticosteroids
717:
Or place the second kind in brackets? Or whatever? --
990:? The latter would currently contain a single page ( 932:? The latter would currently contain a single page ( 110:, a collaborative effort to improve the coverage of 487: 353: 440:... with the cell color coding being based on the 1177:instead of "Preparations..." for the same reason. 1175:Category:Drugs for treatment of wounds and ulcers 1139:Ok, I'm back again! I'd propose the following: 976:A: Break down into 4th level categories or not? 60:does not require a rating on Knowledge (XXG)'s 817:I proposed this for the top level categories ( 18:Knowledge (XXG) talk:WikiProject Pharmacology 8: 179:. Thanks again everyone for your help! --- 930:Enzymes for treatment of wounds and ulcers 469:don't exist, so I'd suggest using either " 75: 373:Drugs acting on the cardiovascular system 311:Drugs acting on the cardiovascular system 208:Drugs acting on the cardiovascular system 168:we could start developing the table with 124:Knowledge (XXG):WikiProject Pharmacology 1154:because 1. the pages in this category ( 880:Further experiments on table formatting 77: 1190:Category:Drugs by mechanism of action 1044:Category:Drugs by mechanism of action 350:ATC code to category conversion table 7: 49: 47: 1242:NA-importance pharmacology articles 1237:Project-Class pharmacology articles 1169:Call the category corresponding to 1142:Call the category corresponding to 865:Ok, thanks again for your help. --- 66:It is of interest to the following 924:Do we need the subcategories D03A 397:Drugs acting on the sensory organs 323:Drugs acting on the sensory organs 231:Drugs acting on the sensory organs 24: 1247:WikiProject Pharmacology articles 499:Other ATC codes in this category 459:The colour coding is a good idea. 127:Template:WikiProject Pharmacology 104:This page is within the scope of 97: 79: 48: 988:Systemic anti-acne preparations 962:: Is there any use of having a 477:Ophtalmologicals") or perhaps " 1214:13:36, 13 September 2009 (UTC) 1034:could be a subcategory of D04 984:Topical anti-acne preparations 948:" instead of the established " 421:Antiglaucoma drugs and miotics 333:Antiglaucoma drugs and miotics 300:Proposed categorization scheme 246:Antiglaucoma drugs and miotics 172:;) and see what issues arise? 1: 1109:NP. I don't mind waiting. --- 1040:Category:Receptor antagonists 905:Some questions and thoughts: 442:main table in the ATC article 118:and see a list of open tasks. 305:Drugs by target organ system 199:Drugs by target organ system 1119:17:46, 31 August 2009 (UTC) 1105:16:35, 31 August 2009 (UTC) 1082:17:44, 30 August 2009 (UTC) 1060:16:51, 30 August 2009 (UTC) 1025:02:06, 30 August 2009 (UTC) 1263: 1032:Category:H1 antihistamines 1008:12:05, 9 August 2009 (UTC) 776:I moved the table over to 25: 898:11:14, 27 July 2009 (UTC) 875:13:40, 21 July 2009 (UTC) 856:19:17, 22 July 2009 (UTC) 831:19:17, 22 July 2009 (UTC) 801:19:17, 22 July 2009 (UTC) 765:16:58, 17 July 2009 (UTC) 727:13:25, 16 July 2009 (UTC) 713:13:16, 16 July 2009 (UTC) 696:00:32, 16 July 2009 (UTC) 672:17:50, 14 July 2009 (UTC) 641:02:40, 14 July 2009 (UTC) 615:07:52, 13 July 2009 (UTC) 589:23:19, 12 July 2009 (UTC) 577:rough start to this table 565:16:39, 12 July 2009 (UTC) 546:13:08, 12 July 2009 (UTC) 530:09:04, 12 July 2009 (UTC) 454:21:01, 11 July 2009 (UTC) 285:18:52, 11 July 2009 (UTC) 189:14:17, 11 July 2009 (UTC) 92: 74: 1148:Category:Glucocorticoids 968:Category:Glucocorticoids 791:That is okay with me. -- 107:WikiProject Pharmacology 950:H1 receptor antagonists 496:Corresponding category 362:Corresponding category 1036:Category:Antipruritics 1048:Category:Cicatrizants 603:tables within a table 295:Categorization scheme 130:pharmacology articles 1204:Thoughts, anyone? -- 1195:I am not sure about 966:as opposed to just 952:" because they are 770:A couple things... 1162:and all the rest) 1156:Methylprednisolone 62:content assessment 946:H1 antihistamines 518: 517: 438: 437: 409:Ophthalmologicals 328:Ophthalmologicals 240:Ophthalmologicals 160: 159: 146: 145: 142: 141: 138: 137: 1254: 736:A few thoughts: 488: 354: 148: 132: 131: 128: 125: 122: 101: 94: 93: 83: 76: 53: 52: 51: 44: 38: 1262: 1261: 1257: 1256: 1255: 1253: 1252: 1251: 1227: 1226: 1188:in the tree of 1173:something like 882: 352: 297: 165: 129: 126: 123: 120: 119: 42: 41: 34: 30: 22: 21: 20: 12: 11: 5: 1260: 1258: 1250: 1249: 1244: 1239: 1229: 1228: 1225: 1224: 1223: 1222: 1221: 1220: 1219: 1218: 1217: 1216: 1202: 1201: 1200: 1193: 1178: 1167: 1160:Hydrocortisone 1128: 1127: 1126: 1125: 1124: 1123: 1122: 1121: 1087: 1086: 1085: 1084: 1063: 1062: 996: 995: 977: 971: 957: 939: 938: 937: 922: 881: 878: 863: 862: 861: 860: 859: 858: 841: 840: 836: 835: 834: 833: 812: 811: 806: 805: 804: 803: 786: 785: 781: 768: 767: 753: 752: 751: 748: 744: 740: 734: 730: 729: 715: 683: 682: 681: 680: 679: 678: 677: 676: 675: 674: 650: 649: 648: 647: 646: 645: 644: 643: 622: 621: 620: 619: 618: 617: 594: 593: 592: 591: 570: 569: 568: 567: 549: 548: 516: 515: 510: 505: 501: 500: 497: 494: 486: 485: 482: 467:ATC code S01ED 463: 460: 436: 435: 430: 424: 423: 418: 412: 411: 406: 400: 399: 394: 388: 387: 382: 376: 375: 370: 364: 363: 360: 351: 348: 347: 346: 345: 344: 343: 342: 341: 340: 320: 319: 318: 296: 293: 288: 287: 272: 271: 270: 269: 268: 267: 266: 265: 264: 263: 262: 261: 224: 223: 222: 164: 161: 158: 157: 144: 143: 140: 139: 136: 135: 133: 116:the discussion 102: 90: 89: 84: 72: 71: 65: 54: 40: 39: 31: 26: 23: 15: 14: 13: 10: 9: 6: 4: 3: 2: 1259: 1248: 1245: 1243: 1240: 1238: 1235: 1234: 1232: 1215: 1211: 1207: 1203: 1198: 1194: 1191: 1187: 1183: 1179: 1176: 1172: 1168: 1165: 1161: 1157: 1153: 1149: 1145: 1141: 1140: 1138: 1137: 1136: 1135: 1134: 1133: 1132: 1131: 1130: 1129: 1120: 1116: 1112: 1108: 1107: 1106: 1102: 1098: 1093: 1092: 1091: 1090: 1089: 1088: 1083: 1079: 1075: 1071: 1067: 1066: 1065: 1064: 1061: 1057: 1053: 1049: 1045: 1041: 1037: 1033: 1029: 1028: 1027: 1026: 1022: 1018: 1014: 1010: 1009: 1005: 1001: 993: 989: 985: 981: 978: 975: 972: 969: 965: 961: 958: 955: 951: 947: 943: 940: 935: 931: 927: 923: 920: 916: 913: 912: 911: 908: 907: 906: 903: 900: 899: 895: 891: 887: 879: 877: 876: 872: 868: 857: 853: 849: 845: 844: 843: 842: 838: 837: 832: 828: 824: 820: 816: 815: 814: 813: 808: 807: 802: 798: 794: 790: 789: 788: 787: 782: 779: 775: 774: 773: 772: 771: 766: 762: 758: 754: 749: 745: 741: 738: 737: 735: 732: 731: 728: 724: 720: 716: 714: 710: 706: 700: 699: 698: 697: 693: 689: 673: 669: 665: 660: 659: 658: 657: 656: 655: 654: 653: 652: 651: 642: 638: 634: 630: 629: 628: 627: 626: 625: 624: 623: 616: 612: 608: 604: 600: 599: 598: 597: 596: 595: 590: 586: 582: 578: 574: 573: 572: 571: 566: 562: 558: 553: 552: 551: 550: 547: 543: 539: 534: 533: 532: 531: 527: 523: 514: 511: 509: 508:Beta blockers 506: 503: 502: 498: 495: 493: 490: 489: 483: 480: 476: 472: 468: 464: 461: 458: 457: 456: 455: 451: 447: 443: 434: 433:Beta blockers 431: 429: 426: 425: 422: 419: 417: 414: 413: 410: 407: 405: 402: 401: 398: 395: 393: 390: 389: 386: 385:Beta blockers 383: 381: 378: 377: 374: 371: 369: 366: 365: 361: 359: 356: 355: 349: 339: 338:Beta blockers 336: 335: 334: 331: 330: 329: 326: 325: 324: 321: 317: 316:Beta blockers 314: 313: 312: 309: 308: 307: 306: 302: 301: 294: 292: 286: 282: 278: 274: 273: 260: 258: 253: 252:Beta blockers 249: 248: 247: 243: 242: 241: 237: 234: 233: 232: 228: 225: 221: 218: 217:Beta blockers 214: 211: 210: 209: 205: 202: 201: 200: 197: 196: 193: 192: 191: 190: 186: 182: 178: 173: 171: 162: 156: 155: 150: 149: 134: 117: 113: 109: 108: 103: 100: 96: 95: 91: 88: 85: 82: 78: 73: 69: 63: 59: 55: 46: 45: 37: 33: 32: 29: 19: 1197:ATC code D06 1185: 1182:ATC code D04 1171:ATC code D03 1163: 1144:ATC code D07 1011: 997: 992:Isotretinoin 980:ATC code D10 974:ATC code D08 960:ATC code D07 953: 944:AA: I used " 942:ATC code D04 926:Cicatrizants 918: 915:Preparations 914: 910:ATC code D03 904: 901: 883: 864: 769: 684: 519: 439: 303: 299: 298: 289: 254: 220:(also S01ED) 219: 174: 166: 151: 121:Pharmacology 112:Pharmacology 105: 87:Pharmacology 68:WikiProjects 58:project page 57: 36:WT:PHARM:CAT 1150:instead of 1038:as well as 465:Pages like 1231:Categories 1206:ἀνυπόδητος 1097:ἀνυπόδητος 1052:ἀνυπόδητος 1013:ἀνυπόδητος 1000:ἀνυπόδητος 890:ἀνυπόδητος 848:ἀνυπόδητος 823:ἀνυπόδητος 793:ἀνυπόδητος 757:ἀνυπόδητος 719:ἀνυπόδητος 705:ἀνυπόδητος 664:ἀνυπόδητος 607:ἀνυπόδητος 557:ἀνυπόδητος 522:ἀνυπόδητος 277:ἀνυπόδητος 170:ATC code D 152:Archives: 986:and D10B 928:and D03B 492:ATC code 358:ATC code 28:Shortcut 1146:simply 934:Trypsin 250:S01ED: 1180:Break 1111:kilbad 1074:kilbad 1017:kilbad 867:kilbad 747:those. 688:kilbad 633:kilbad 581:kilbad 538:kilbad 504:S01ED 446:kilbad 255:(also 244:S01E: 181:kilbad 64:scale. 919:Drugs 810:D04A? 784:that? 743:look? 479:S01ED 428:S01ED 56:This 16:< 1210:talk 1115:talk 1101:talk 1078:talk 1056:talk 1021:talk 1004:talk 894:talk 871:talk 852:talk 827:talk 797:talk 761:talk 723:talk 709:talk 692:talk 668:talk 637:talk 611:talk 585:talk 561:talk 542:talk 526:talk 450:talk 416:S01E 281:talk 185:talk 1186:and 1164:are 954:not 917:or 513:C07 475:S01 471:S01 404:S01 380:C07 257:C07 236:S01 213:C07 1233:: 1212:) 1158:, 1117:) 1103:) 1095:-- 1080:) 1058:) 1023:) 1006:) 994:). 936:). 896:) 873:) 854:) 829:) 799:) 763:) 755:-- 725:) 711:) 694:) 670:) 662:-- 639:) 613:) 587:) 563:) 555:-- 544:) 528:) 520:-- 452:) 283:) 238:: 229:: 215:: 206:: 187:) 1208:( 1192:. 1113:( 1099:( 1076:( 1054:( 1019:( 1002:( 970:? 892:( 869:( 850:( 825:( 795:( 780:. 759:( 721:( 707:( 690:( 666:( 635:( 609:( 583:( 559:( 540:( 524:( 448:( 392:S 368:C 279:( 259:) 227:S 204:C 183:( 154:1 70::

Index

Knowledge (XXG) talk:WikiProject Pharmacology
Shortcut
WT:PHARM:CAT
content assessment
WikiProjects
WikiProject icon
Pharmacology
WikiProject icon
WikiProject Pharmacology
Pharmacology
the discussion
1
ATC code D
Knowledge (XXG):WikiProject_Pharmacology/Categorization/Scheme#ATC_code_to_category_conversion_table
kilbad
talk
14:17, 11 July 2009 (UTC)
Drugs by target organ system
C
Drugs acting on the cardiovascular system
C07
Beta blockers
S
Drugs acting on the sensory organs
S01
Ophthalmologicals
Antiglaucoma drugs and miotics
Beta blockers
C07
ἀνυπόδητος

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.